NavaX Translation

NavaX Translation is a multilingual case processing capability developed through a partnership between ArisGlobal and TransPerfect Life Sciences. It is designed for global pharmacovigilance teams that handle non-English safety reports and need to process them accurately and in compliance with regional regulatory requirements. The solution integrates certified, pharma-grade translation directly into ArisGlobal's LifeSphere Safety workflows.

The tool addresses a common challenge in global pharmacovigilance: rising case volumes combined with multilingual safety reports create delays, manual work, and compliance risks. Traditional translation approaches rely on disconnected tools, slow handoffs, inconsistent quality, and costly regional linguistic resources. NavaX Translation replaces these disconnected processes with an automated, integrated workflow.

Core Capabilities

• Automated multilingual case intake: Intelligent language detection identifies non-English safety forms and routes them for translation without requiring manual steps.
• Pharma-grade translation quality: Translations are produced using pharma-specific language models combined with expert human linguists, targeting accuracy, consistency, and regulatory-ready output.
• Workflow integration via API: Translated forms and data are returned directly into LifeSphere Safety through an API connection, removing the need for manual copying, uploading, or use of external tools.
• Compliance support: Validated translations are designed to meet global pharmacovigilance compliance requirements across regional regulatory authorities.
• Scalable global operations: End-to-end automation supports high-volume safety case intake across multiple markets.

How the Workflow Operates

1. A non-English safety form enters the LifeSphere Safety processing workflow.
2. Intelligent language detection instantly identifies the language of the incoming form.
3. The form is automatically routed to TransPerfect's translation process, which uses pharma-specific language models and expert linguists.
4. The certified translation is returned to LifeSphere Safety via API integration.
5. Translated forms and associated data are available within the workflow with no manual intervention required.

Problems Addressed

• Delays caused by manual translation handoffs and disconnected tools.
• Inconsistent translation quality across regional linguistic resources.
• Compliance risks associated with unvalidated or inaccurate translations of safety reports.
• High operational costs tied to managing multilingual case intake at scale.
• Human error introduced through manual copying or re-entry of translated content.

NavaX Translation is built on ArisGlobal's LifeSphere platform and delivered through a strategic partnership with TransPerfect Life Sciences. ArisGlobal works with more than 220 global life sciences companies, CROs, and government health authorities, including regulatory bodies such as the FDA, Health Canada, and NMPA. The company is headquartered in the United States with regional offices in Europe, India, Japan, and China.